US Broker Ratings

Alphatec Holdings, Inc. (ATEC) Investor Outlook: Exploring a 65% Potential Upside in Medical Device Innovation

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector, is making waves with its innovative approach to spinal disorder treatments. Specializing in advanced..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a Potential 323.88% Upside

For investors with a keen interest in the biotechnology sector, Dyne Therapeutics, Inc. (NASDAQ: DYN) presents a compelling narrative. Specializing in the development of therapeutics for..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a Potential 139.73% Upside

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a UK-based biotechnology company, is capturing the attention of investors with its innovative approach to drug development and a promising potential..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A Biotech Play with 65.91% Upside Potential

MoonLake Immunotherapeutics (NASDAQ: MLTX) is commanding the attention of investors as it navigates the competitive waters of the biotechnology sector. With a market capitalization of $3..

AtriCure, Inc. (ATRC) Stock Analysis: A Promising Upside of 52.24% in the Healthcare Sector

AtriCure, Inc. (NASDAQ: ATRC), a key player in the medical instruments and supplies industry, is capturing investor attention with a noteworthy potential upside of 52.24%. As..

CONMED Corporation (CNMD) Stock Analysis: Exploring 27.88% Potential Upside in Medical Device Innovations

CONMED Corporation (NASDAQ: CNMD), a notable player in the healthcare sector, has been capturing the attention of investors with its extensive portfolio of medical devices. Headquartered..

Artivion, Inc. (AORT) Stock Analysis: Navigating Growth Potential Amidst Mixed Financial Signals

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its unique product offerings..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Navigating the Biotech Frontier with 133.7% Revenue Growth

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) has emerged as a noteworthy player in the biotechnology sector, capturing investor attention with its impressive 133.7% revenue growth. As a..

LifeStance Health Group (LFST): Analyst Ratings Point to a 71% Upside Potential in the Mental Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is carving out a significant niche in the healthcare sector, focusing on the ever-growing demand for mental health services. With..

89bio, Inc. (ETNB) Stock Analysis: Unpacking the 199.94% Potential Upside

For investors seeking opportunities in the biotechnology sector, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing proposition. With a market capitalization of $1.43 billion, this clinical-stage biopharmaceutical..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Promising 40% Upside in Biotechnology

Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the biotechnology sector with a promising pipeline and notable analyst support, offering a potential upside of..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 41% Upside Potential and Analysts’ Consensus

Surgery Partners, Inc. (NASDAQ: SGRY) has captured the attention of investors with its dynamic presence in the healthcare sector, particularly in the medical care facilities industry...

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 27% Potential Upside in the Healthcare Sector

Investors eyeing the healthcare sector may find UFP Technologies, Inc. (UFPT) an intriguing opportunity, especially considering its robust growth metrics and potential upside. With a market..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 27% Upside Potential

For investors seeking opportunities in the healthcare sector, Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling case. With a market capitalization of $1.11 billion, Pacira BioSciences..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 56.90% Potential Upside in the Healthcare Sector

Neogen Corporation (NASDAQ: NEOG) is making waves in the healthcare sector, particularly within the diagnostics and research industry, with a remarkable potential upside of 56.90%. As..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 25.83% Upside Potential in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a prominent player in the healthcare sector, specifically within the niche of medical instruments and supplies. Headquartered in Burlington, Massachusetts,..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a 23.73% Potential Upside for Investors

Supernus Pharmaceuticals, Inc. (SUPN), a key player in the healthcare sector, is attracting significant investor attention with a compelling potential upside of 23.73%. This biopharmaceutical company,..

PACS Group, Inc. (PACS) Investor Outlook: A 136% Upside Potential in Healthcare

PACS Group, Inc. (PACS) is an intriguing player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $2 billion,..

Ardent Health, Inc. (ARDT) Stock Analysis: A 48.74% Potential Upside Sparks Investor Interest

Ardent Health, Inc. (ARDT) is capturing the attention of investors with its promising growth potential, highlighted by a potential upside of 48.74%. As a major player..

Mesoblast Limited (MESO) Stock Analysis: A Biotech with a 147.93% Upside Potential

Mesoblast Limited (MESO), a biotechnology company headquartered in Melbourne, Australia, is capturing investor attention due to its significant upside potential. With a market capitalization of $1.38..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds